Acadia Pharmaceuticals (ACAD) Selling, General & Administrative (2010 - 2026)
Acadia Pharmaceuticals (ACAD) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-1.52 Mn |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
2.17 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
-7.36 Mn |
| 10 |
Acadia Pharmaceuticals |
3.68 Bn |
2.83 Bn |
243.27 Mn |
171.02 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
171.02 Mn |
| Dec 31, 2025 |
155.62 Mn |
| Sep 30, 2025 |
133.40 Mn |
| Jun 30, 2025 |
133.51 Mn |
| Mar 31, 2025 |
126.37 Mn |
| Dec 31, 2024 |
130.08 Mn |
| Sep 30, 2024 |
133.29 Mn |
| Jun 30, 2024 |
117.06 Mn |
| Mar 31, 2024 |
107.99 Mn |
| Dec 31, 2023 |
111.47 Mn |
| Sep 30, 2023 |
97.89 Mn |
| Jun 30, 2023 |
95.97 Mn |
| Mar 31, 2023 |
101.24 Mn |
| Dec 31, 2022 |
104.40 Mn |
| Sep 30, 2022 |
78.11 Mn |
| Jun 30, 2022 |
89.90 Mn |
| Mar 31, 2022 |
96.68 Mn |
| Dec 31, 2021 |
105.91 Mn |
| Sep 30, 2021 |
81.67 Mn |
| Jun 30, 2021 |
96.79 Mn |
